$2.32
-0.04-1.61%
Last update: 9:31 AM
15 minutes delayed
Armata Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Armata Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $-0.25 | $-0.44 | 43.2 % |
Mar 2024 | 2024-05-07 | $-0.69 | $-0.31 | -122.6 % |
Dec 2023 | 2024-03-21 | $-0.55 | $-0.35 | -57.1 % |
Sep 2023 | 2023-11-14 | $-0.86 | $-0.31 | -177.4 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $0 | $1.13M | -100.0 % |
Mar 2024 | 2024-05-07 | $966.00K | $1.10M | -12.2 % |
Dec 2023 | 2024-03-21 | $1.53M | $860.00K | 77.7 % |
Sep 2023 | 2023-11-14 | $1.23M | $950.00K | 28.9 % |
Armata Pharmaceuticals (ARMP) is scheduled to report earnings on November 12, 2024. The last reported earnings were for reported on August 13, 2024 for Q2.
The Actual EPS was $-0.25, which beat the estimate of $-0.44.
The Actual Revenue was $0K, which missed the estimate of $1.1M.
Browse earnings estimates, EPS, and revenue on all stocks.